The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Particle-Enhanced Turbidimetric Immunoassay Market Research Report 2025
Synopsis
Particle-Enhanced Turbidimetric Immunoassays or PETIA is a biochemical process which uses optical change i.e. change in opaqueness caused by the agglutination of immunoparticles in the sample. These immunopartilcles are nothing but nanoparticles coated with antibodies. Their reaction with taken sample makes the mixture cloudy. A monochromatic light is then passed through the mixture to determine the opaqueness of turbidity of the mixture. Based on the absorption of light and pre-determined calibrations as per known and standardized concentrations, quantitative measurements of body fluid components like proteins, pathogens, serums, urine, plasma, etc can then be taken.
The global Particle-Enhanced Turbidimetric Immunoassay market was valued at US$ 1836 million in 2023 and is anticipated to reach US$ 3076.7 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Life science reagents are the fundamental materials for life science research and development, and are widely used as consumable tools in life science research activities. According to Frost&Sullivan's data, the global market size of biological reagents has reached US $12.8 billion in 2015 and US $17.5 billion in 2019, with a Compound annual growth rate of 8.1%.
This report aims to provide a comprehensive presentation of the global market for Particle-Enhanced Turbidimetric Immunoassay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Particle-Enhanced Turbidimetric Immunoassay.
Report Scope
The Particle-Enhanced Turbidimetric Immunoassay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Particle-Enhanced Turbidimetric Immunoassay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Particle-Enhanced Turbidimetric Immunoassay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gentian Diagnostics
Thermo-Fisher Scientific
Buehlmann
Biotec
Abbott Laboratories
Roche
Siemens
Danaher Corporation
Diasorin SPA
Sysmex Corporation
Biomerieux
QIAGEN
Agilent Technologies
Segment by Type
Kits or Reagents
Service
Segment by Application
Hospitals
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Particle-Enhanced Turbidimetric Immunoassay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Particle-Enhanced Turbidimetric Immunoassays or PETIA is a biochemical process which uses optical change i.e. change in opaqueness caused by the agglutination of immunoparticles in the sample. These immunopartilcles are nothing but nanoparticles coated with antibodies. Their reaction with taken sample makes the mixture cloudy. A monochromatic light is then passed through the mixture to determine the opaqueness of turbidity of the mixture. Based on the absorption of light and pre-determined calibrations as per known and standardized concentrations, quantitative measurements of body fluid components like proteins, pathogens, serums, urine, plasma, etc can then be taken.
The global Particle-Enhanced Turbidimetric Immunoassay market was valued at US$ 1836 million in 2023 and is anticipated to reach US$ 3076.7 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Life science reagents are the fundamental materials for life science research and development, and are widely used as consumable tools in life science research activities. According to Frost&Sullivan's data, the global market size of biological reagents has reached US $12.8 billion in 2015 and US $17.5 billion in 2019, with a Compound annual growth rate of 8.1%.
This report aims to provide a comprehensive presentation of the global market for Particle-Enhanced Turbidimetric Immunoassay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Particle-Enhanced Turbidimetric Immunoassay.
Report Scope
The Particle-Enhanced Turbidimetric Immunoassay market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Particle-Enhanced Turbidimetric Immunoassay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Particle-Enhanced Turbidimetric Immunoassay companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gentian Diagnostics
Thermo-Fisher Scientific
Buehlmann
Biotec
Abbott Laboratories
Roche
Siemens
Danaher Corporation
Diasorin SPA
Sysmex Corporation
Biomerieux
QIAGEN
Agilent Technologies
Segment by Type
Kits or Reagents
Service
Segment by Application
Hospitals
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Particle-Enhanced Turbidimetric Immunoassay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kits or Reagents
1.2.3 Service
1.3 Market by Application
1.3.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Academic and Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Perspective (2019-2030)
2.2 Particle-Enhanced Turbidimetric Immunoassay Growth Trends by Region
2.2.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Region (2019-2024)
2.2.3 Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Region (2025-2030)
2.3 Particle-Enhanced Turbidimetric Immunoassay Market Dynamics
2.3.1 Particle-Enhanced Turbidimetric Immunoassay Industry Trends
2.3.2 Particle-Enhanced Turbidimetric Immunoassay Market Drivers
2.3.3 Particle-Enhanced Turbidimetric Immunoassay Market Challenges
2.3.4 Particle-Enhanced Turbidimetric Immunoassay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Particle-Enhanced Turbidimetric Immunoassay Players by Revenue
3.1.1 Global Top Particle-Enhanced Turbidimetric Immunoassay Players by Revenue (2019-2024)
3.1.2 Global Particle-Enhanced Turbidimetric Immunoassay Revenue Market Share by Players (2019-2024)
3.2 Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Particle-Enhanced Turbidimetric Immunoassay Revenue
3.4 Global Particle-Enhanced Turbidimetric Immunoassay Market Concentration Ratio
3.4.1 Global Particle-Enhanced Turbidimetric Immunoassay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Particle-Enhanced Turbidimetric Immunoassay Revenue in 2023
3.5 Particle-Enhanced Turbidimetric Immunoassay Key Players Head office and Area Served
3.6 Key Players Particle-Enhanced Turbidimetric Immunoassay Product Solution and Service
3.7 Date of Enter into Particle-Enhanced Turbidimetric Immunoassay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Particle-Enhanced Turbidimetric Immunoassay Breakdown Data by Type
4.1 Global Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Type (2019-2024)
4.2 Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Type (2025-2030)
5 Particle-Enhanced Turbidimetric Immunoassay Breakdown Data by Application
5.1 Global Particle-Enhanced Turbidimetric Immunoassay Historic Market Size by Application (2019-2024)
5.2 Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Particle-Enhanced Turbidimetric Immunoassay Market Size (2019-2030)
6.2 North America Particle-Enhanced Turbidimetric Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2019-2024)
6.4 North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size (2019-2030)
7.2 Europe Particle-Enhanced Turbidimetric Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2019-2024)
7.4 Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size (2019-2030)
8.2 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2019-2024)
8.4 Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size (2019-2030)
9.2 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2019-2024)
9.4 Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size (2019-2030)
10.2 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2019-2024)
10.4 Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gentian Diagnostics
11.1.1 Gentian Diagnostics Company Detail
11.1.2 Gentian Diagnostics Business Overview
11.1.3 Gentian Diagnostics Particle-Enhanced Turbidimetric Immunoassay Introduction
11.1.4 Gentian Diagnostics Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.1.5 Gentian Diagnostics Recent Development
11.2 Thermo-Fisher Scientific
11.2.1 Thermo-Fisher Scientific Company Detail
11.2.2 Thermo-Fisher Scientific Business Overview
11.2.3 Thermo-Fisher Scientific Particle-Enhanced Turbidimetric Immunoassay Introduction
11.2.4 Thermo-Fisher Scientific Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.2.5 Thermo-Fisher Scientific Recent Development
11.3 Buehlmann
11.3.1 Buehlmann Company Detail
11.3.2 Buehlmann Business Overview
11.3.3 Buehlmann Particle-Enhanced Turbidimetric Immunoassay Introduction
11.3.4 Buehlmann Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.3.5 Buehlmann Recent Development
11.4 Biotec
11.4.1 Biotec Company Detail
11.4.2 Biotec Business Overview
11.4.3 Biotec Particle-Enhanced Turbidimetric Immunoassay Introduction
11.4.4 Biotec Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.4.5 Biotec Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Particle-Enhanced Turbidimetric Immunoassay Introduction
11.5.4 Abbott Laboratories Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.5.5 Abbott Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Particle-Enhanced Turbidimetric Immunoassay Introduction
11.6.4 Roche Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Siemens
11.7.1 Siemens Company Detail
11.7.2 Siemens Business Overview
11.7.3 Siemens Particle-Enhanced Turbidimetric Immunoassay Introduction
11.7.4 Siemens Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.7.5 Siemens Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Detail
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Particle-Enhanced Turbidimetric Immunoassay Introduction
11.8.4 Danaher Corporation Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.8.5 Danaher Corporation Recent Development
11.9 Diasorin SPA
11.9.1 Diasorin SPA Company Detail
11.9.2 Diasorin SPA Business Overview
11.9.3 Diasorin SPA Particle-Enhanced Turbidimetric Immunoassay Introduction
11.9.4 Diasorin SPA Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.9.5 Diasorin SPA Recent Development
11.10 Sysmex Corporation
11.10.1 Sysmex Corporation Company Detail
11.10.2 Sysmex Corporation Business Overview
11.10.3 Sysmex Corporation Particle-Enhanced Turbidimetric Immunoassay Introduction
11.10.4 Sysmex Corporation Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.10.5 Sysmex Corporation Recent Development
11.11 Biomerieux
11.11.1 Biomerieux Company Detail
11.11.2 Biomerieux Business Overview
11.11.3 Biomerieux Particle-Enhanced Turbidimetric Immunoassay Introduction
11.11.4 Biomerieux Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.11.5 Biomerieux Recent Development
11.12 QIAGEN
11.12.1 QIAGEN Company Detail
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Particle-Enhanced Turbidimetric Immunoassay Introduction
11.12.4 QIAGEN Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.12.5 QIAGEN Recent Development
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Detail
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Particle-Enhanced Turbidimetric Immunoassay Introduction
11.13.4 Agilent Technologies Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
11.13.5 Agilent Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Kits or Reagents
Table 3. Key Players of Service
Table 4. Global Particle-Enhanced Turbidimetric Immunoassay Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Region (2019-2024)
Table 8. Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Region (2025-2030)
Table 10. Particle-Enhanced Turbidimetric Immunoassay Market Trends
Table 11. Particle-Enhanced Turbidimetric Immunoassay Market Drivers
Table 12. Particle-Enhanced Turbidimetric Immunoassay Market Challenges
Table 13. Particle-Enhanced Turbidimetric Immunoassay Market Restraints
Table 14. Global Particle-Enhanced Turbidimetric Immunoassay Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Players (2019-2024)
Table 16. Global Top Particle-Enhanced Turbidimetric Immunoassay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Particle-Enhanced Turbidimetric Immunoassay as of 2023)
Table 17. Ranking of Global Top Particle-Enhanced Turbidimetric Immunoassay Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Particle-Enhanced Turbidimetric Immunoassay Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Particle-Enhanced Turbidimetric Immunoassay Product Solution and Service
Table 21. Date of Enter into Particle-Enhanced Turbidimetric Immunoassay Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Market Share by Type (2019-2024)
Table 25. Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Market Share by Type (2025-2030)
Table 27. Global Particle-Enhanced Turbidimetric Immunoassay Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Market Share by Application (2019-2024)
Table 29. Global Particle-Enhanced Turbidimetric Immunoassay Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Particle-Enhanced Turbidimetric Immunoassay Revenue Market Share by Application (2025-2030)
Table 31. North America Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size by Country (2025-2030) & (US$ Million)
Table 46. Gentian Diagnostics Company Detail
Table 47. Gentian Diagnostics Business Overview
Table 48. Gentian Diagnostics Particle-Enhanced Turbidimetric Immunoassay Product
Table 49. Gentian Diagnostics Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 50. Gentian Diagnostics Recent Development
Table 51. Thermo-Fisher Scientific Company Detail
Table 52. Thermo-Fisher Scientific Business Overview
Table 53. Thermo-Fisher Scientific Particle-Enhanced Turbidimetric Immunoassay Product
Table 54. Thermo-Fisher Scientific Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 55. Thermo-Fisher Scientific Recent Development
Table 56. Buehlmann Company Detail
Table 57. Buehlmann Business Overview
Table 58. Buehlmann Particle-Enhanced Turbidimetric Immunoassay Product
Table 59. Buehlmann Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 60. Buehlmann Recent Development
Table 61. Biotec Company Detail
Table 62. Biotec Business Overview
Table 63. Biotec Particle-Enhanced Turbidimetric Immunoassay Product
Table 64. Biotec Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 65. Biotec Recent Development
Table 66. Abbott Laboratories Company Detail
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Particle-Enhanced Turbidimetric Immunoassay Product
Table 69. Abbott Laboratories Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 70. Abbott Laboratories Recent Development
Table 71. Roche Company Detail
Table 72. Roche Business Overview
Table 73. Roche Particle-Enhanced Turbidimetric Immunoassay Product
Table 74. Roche Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Siemens Company Detail
Table 77. Siemens Business Overview
Table 78. Siemens Particle-Enhanced Turbidimetric Immunoassay Product
Table 79. Siemens Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 80. Siemens Recent Development
Table 81. Danaher Corporation Company Detail
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Particle-Enhanced Turbidimetric Immunoassay Product
Table 84. Danaher Corporation Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 85. Danaher Corporation Recent Development
Table 86. Diasorin SPA Company Detail
Table 87. Diasorin SPA Business Overview
Table 88. Diasorin SPA Particle-Enhanced Turbidimetric Immunoassay Product
Table 89. Diasorin SPA Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 90. Diasorin SPA Recent Development
Table 91. Sysmex Corporation Company Detail
Table 92. Sysmex Corporation Business Overview
Table 93. Sysmex Corporation Particle-Enhanced Turbidimetric Immunoassay Product
Table 94. Sysmex Corporation Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 95. Sysmex Corporation Recent Development
Table 96. Biomerieux Company Detail
Table 97. Biomerieux Business Overview
Table 98. Biomerieux Particle-Enhanced Turbidimetric Immunoassay Product
Table 99. Biomerieux Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 100. Biomerieux Recent Development
Table 101. QIAGEN Company Detail
Table 102. QIAGEN Business Overview
Table 103. QIAGEN Particle-Enhanced Turbidimetric Immunoassay Product
Table 104. QIAGEN Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 105. QIAGEN Recent Development
Table 106. Agilent Technologies Company Detail
Table 107. Agilent Technologies Business Overview
Table 108. Agilent Technologies Particle-Enhanced Turbidimetric Immunoassay Product
Table 109. Agilent Technologies Revenue in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024) & (US$ Million)
Table 110. Agilent Technologies Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Particle-Enhanced Turbidimetric Immunoassay Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Type: 2023 VS 2030
Figure 3. Kits or Reagents Features
Figure 4. Service Features
Figure 5. Global Particle-Enhanced Turbidimetric Immunoassay Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Academic and Research Institutions Case Studies
Figure 9. Pharmaceutical and Biotechnology Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Particle-Enhanced Turbidimetric Immunoassay Report Years Considered
Figure 12. Global Particle-Enhanced Turbidimetric Immunoassay Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Particle-Enhanced Turbidimetric Immunoassay Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Region: 2023 VS 2030
Figure 15. Global Particle-Enhanced Turbidimetric Immunoassay Market Share by Players in 2023
Figure 16. Global Top Particle-Enhanced Turbidimetric Immunoassay Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Particle-Enhanced Turbidimetric Immunoassay as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Particle-Enhanced Turbidimetric Immunoassay Revenue in 2023
Figure 18. North America Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Particle-Enhanced Turbidimetric Immunoassay Market Share by Country (2019-2030)
Figure 20. United States Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Particle-Enhanced Turbidimetric Immunoassay Market Share by Country (2019-2030)
Figure 24. Germany Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Particle-Enhanced Turbidimetric Immunoassay Market Share by Region (2019-2030)
Figure 32. China Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Particle-Enhanced Turbidimetric Immunoassay Market Share by Country (2019-2030)
Figure 40. Mexico Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Particle-Enhanced Turbidimetric Immunoassay Market Share by Country (2019-2030)
Figure 44. Turkey Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Particle-Enhanced Turbidimetric Immunoassay Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Gentian Diagnostics Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 47. Thermo-Fisher Scientific Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 48. Buehlmann Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 49. Biotec Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 50. Abbott Laboratories Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 52. Siemens Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 53. Danaher Corporation Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 54. Diasorin SPA Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 55. Sysmex Corporation Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 56. Biomerieux Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 57. QIAGEN Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 58. Agilent Technologies Revenue Growth Rate in Particle-Enhanced Turbidimetric Immunoassay Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
